Latest Commercialisation News

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Estrella Resources has completed its 2025 drilling program at the Werumata Limestone Project in Timor-Leste, reporting broad, high-grade limestone and chalk intersections that pave the way for a maiden JORC resource estimate.

Fortuna Metals has appointed two seasoned technical consultants to fast-track resource development and metallurgical planning at its Mkanda rutile and graphite project in Malawi, signalling a move towards resource estimation and potential commercialisation.

Galilee Energy has confirmed the final location for its Zydeco-1 well in Louisiana, targeting significant gas and condensate resources with drilling set for the second quarter of 2026. The well also aims to explore additional oil potential, optimising costs and environmental impact.

Elixir Energy has completed drilling the Lorelle-3H well in Queensland’s Taroom Trough, achieving over 1,000 metres of high-quality net gas-condensate pay and setting a new benchmark for lateral drilling in the basin. A multi-stage fracture stimulation and production test is planned for Q2 2026, potentially paving the way for Elixir’s first reserves booking.

Emperor Energy has successfully raised $17.5 million to advance drilling of its Judith-2 appraisal well, aiming to unlock a major gas resource in Victoria’s Gippsland Basin. The capital raise underscores strong investor confidence as the company moves closer to proving commercial gas flow rates.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

Forte Energy has completed a major acquisition of oil leases in Alaska’s National Petroleum Reserve, with technical work underway on the promising Harrier Prospect and cost-saving lease fee suspensions boosting near-term flexibility.

dorsaVi has initiated early-stage evaluation of resistive RAM (RRAM) test chips, marking a key step toward an advanced 22-nm memory platform designed to meet rising AI-driven demands in edge computing.

Australian Oil Company Limited has formalised a 12-month crude oil lifting agreement with IOR Energy for its Emu Apple Oil Field, paving the way for steady cash flow and further development in the Surat Basin.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.